Interestingly, LMTK2 expression changes differently in affected (frontal cortex) and non-affected (cerebellum) brain regions in Alzheimer’s disease post-mortem brains. The gene discussed is LMTK2; the disease is early-onset autosomal dominant Alzheimer disease.